RIYADH —The Saudi Food and Drug Authority (SFDA) has granted marketing authorization for an innovative medical device utilizing next-generation biosensor technology. The device enables continuous, real-time, and accurate monitoring of blood glucose and ketone levels around the clock, supporting improved diabetes management and accelerating clinical response times for critical cases. Regulatory approval was facilitated through the SFDA’s Innovative Medical Devices pathway, designed to accelera...